|
BSDC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.115900E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.356030E-02 |
| Normal-vs-Stage2 |
3.011700E-02 |
| Normal-vs-Stage3 |
1.283400E-03 |
| Normal-vs-Stage4 |
2.843900E-02 |
| Stage1-vs-Stage2 |
7.425000E-01 |
| Stage1-vs-Stage3 |
2.381800E-01 |
| Stage1-vs-Stage4 |
9.528200E-01 |
| Stage2-vs-Stage3 |
6.224400E-01 |
| Stage2-vs-Stage4 |
8.198000E-01 |
| Stage3-vs-Stage4 |
4.136800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.256200E-03 |
| Normal-vs-AfricanAmerican |
8.345200E-01 |
| Normal-vs-Asian |
2.633500E-02 |
| Caucasian-vs-AfricanAmerican |
8.100400E-02 |
| Caucasian-vs-Asian |
9.568600E-01 |
| AfricanAmerican-vs-Asian |
1.161450E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.643100E-03 |
| Normal-vs-Female |
5.897000E-03 |
| Male-vs-Female |
9.799600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.325600E-02 |
| Normal-vs-Age(41-60Yrs) |
8.202000E-03 |
| Normal-vs-Age(61-80Yrs) |
4.218000E-04 |
| Normal-vs-Age(81-100Yrs) |
6.369400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.362800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.020350E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.174400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.634400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.651600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.221600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.204000E-02 |
| Classical-VS-Follicular |
1.962990E-01 |
| Classical-VS-Other |
2.073400E-01 |
| Classical-VS-Normal |
2.834000E-02 |
| Tall-VS-Follicular |
4.321200E-01 |
| Tall-VS-Other |
7.711800E-01 |
| Tall-VS-Normal |
1.760060E-03 |
| Follicular-VS-Other |
6.035000E-01 |
| Follicular-VS-Normal |
9.421600E-03 |
| Other-VS-Normal |
4.709800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.901200E-03 |
| Normal-vs-N1 |
1.030860E-04 |
| N0-vs-N1 |
7.320100E-02 |
|
|
